Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: A phase I study von Moltoff, Carla F.M., Prinssen, Helma M., Kenemans, Peter, Hof, Arjan C. van, Hollander, Wim den, Verheijen, René H.M.

Volltext

Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose von van Hof, A C, Molthoff, C F, Davies, Q, Perkins, A C, Verheijen, R H, Kenemans, P, den Hollander, W, Wilhelm, A J, Baker, T S, Sopwith, M, Frier, M, Symonds, E M, Roos, J C

Volltext

Biodistribution of 111 In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01 von Prinssen, Helma M., Molthoff, Carla F. M., Verheijen, René H. M., Broadhead, Tim J., Kenemans, Peter, Roos, Jan C., Davies, Quentin, van Hof, Arjan C., Frier, Malcolm, den Hollander, Wim, Wilhelm, Abraham J., Baker, Terry S., Sopwith, Mark, Symonds, E. Malcolm, Perkins, Alan C.

Volltext

Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients : influence of prior administration of unlabelled hCTM01 von PRINSSEN, H. M, MOLTHOFF, C. F. M, WILHELM, A. J, BAKER, T. S, SOPWITH, M, SYMONDS, E. M, PERKINS, A. C, VERHEIJEN, R. H. M, BROADHEAD, T. J, KENEMANS, P, ROOS, J. C, DAVIES, Q, VAN HOF, A. C, FRIER, M, DEN HOLLANDER, W

Volltext

Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOV18 : I.V. vs. I.P von VAN ZANTEN-PRZYBYSZ, Iwona, MOLTHOFF, Carla F, ROOS, Jan C, VERHEUEN, René H, VAN HOF, Arjan, BUIST, Marrije R, PRINSSEN, Helma M, DEN HOLLANDER, Wim, KENEMANS, Peter

Volltext

Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p von van Zanten‐Przybysz, Iwona, Molthoff, Carla F., Roos, Jan C., Verheijen, René H., van Hof, Arjan, Buist, Marrije R., Prinssen, Helma M., den Hollander, Wim, Kenemans, Peter

Volltext

Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v.vs. i.p von van Zanten-Przybysz, Iwona, Molthoff, Carla F., Roos, Jan C., Verheijen, René H., van Hof, Arjan, Buist, Marrije R., Prinssen, Helma M., den Hollander, Wim, Kenemans, Peter

Volltext

Optimal experiment design for hypothesis testing applied to functional magnetic resonance imaging von Bombois, X., Dekker, A.J. den, Rojas, C.R., Hjalmarsson, H., Hof, P.M.J. Van den

Volltext